Form 4: U.S. Physical Therapy Director Anne Motsenbocker Acquires Restricted Stock

Sentiment:

SEC Form 4 Filing


Director Anne Motsenbocker acquired 1,882 shares of restricted stock in U.S. Physical Therapy, Inc., according to a recent SEC filing.

Summary

  • Anne Motsenbocker, a director of U.S. Physical Therapy, Inc., acquired 1,882 shares of common stock on May 20, 2025.
  • These shares were granted as restricted stock under the company's 2003 Stock Incentive Plan.
  • The restrictions on the shares will lapse in three tranches: 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, contingent on her continued service as a director.
  • Following the transaction, Motsenbocker directly owns 7,506 shares of U.S. Physical Therapy, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard SEC filing reporting a routine transaction. There's no indication of positive or negative sentiment towards the company's performance or future outlook.

Positives

  • The acquisition of restricted stock aligns the director's interests with those of the shareholders.
  • The vesting schedule encourages continued service as a director.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's financial performance or future prospects, but the vesting schedule of the restricted stock suggests an expectation of continued service by the director.

Industry Context

This filing is a routine disclosure related to insider transactions and is common in publicly traded companies. It provides transparency regarding the ownership of company stock by its directors.

Comparison to Industry Standards

  • Stock grants to directors are a common practice in publicly traded companies to align their interests with shareholders.
  • The vesting schedule is typical for restricted stock grants, encouraging long-term commitment.
  • Comparable companies like ATI Physical Therapy and Select Medical Holdings also utilize stock-based compensation for their executives and directors.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders by aligning the director's interests with the company's long-term performance.

Key Dates

DateDescription
February 25, 2025Date of Power of Attorney execution.
May 20, 2025Date of transaction: acquisition of restricted stock.
May 21, 2025Date of signature for the SEC filing.
August 20, 2025Date of first tranche of restricted stock vesting (941 shares).
November 20, 2025Date of second tranche of restricted stock vesting (470 shares).
March 6, 2026Date of third tranche of restricted stock vesting (471 shares).

Keywords

U.S. Physical Therapy, Director, Anne Motsenbocker, Restricted Stock, SEC Filing, Beneficial Ownership, USPH, Stock Incentive Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.